NYSE · RGNT
Regentis Biomaterials Ltd.
Smart money pulse
What insiders and funds are doing
Buying Insiders: as of Nov 12 Funds: as of Jun 30, 2026
- account_balance6 funds bought, 1 sold in the quarter ended Jun 30, 2026. 4 were new holders.
- infoNo real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.
−100 means everyone selling, +100 everyone buying. This is data, not advice.
How the Pulse works
Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.
Who owns it
6 funds report owning RGNT, up from 3
New4
Added2
Held0
Trimmed0
Sold out1
Last quarter
Who bought and who sold
UBS Group AG
+30%
Change in shares held, biggest holdings first. Bars stop at ±100%.
Insider trades · last 12 months
Real buys and sales
No insider filings loaded for the last 12 months.
Top holders
Biggest funds in RGNT
| Fund | Value | Change |
|---|---|---|
| Rosalind Advisors, Inc. | $2.48M | +179% |
| Warberg Asset Management LLC | $306K | New |
| Jane Street Group, LLC | $153K | New |
| Renaissance Technologies LLC | $47.1K | New |
| UBS Group AG | $1.53K | +30% |